Report Content
Chapter 1 Methodology and Scope
1.1 Market definitions
1.2 Market parameters
1.3 Forecast parameters & calculation
o North America
o Europe
o Asia Pacific
o LATAM
o MEA
1.4 Data Sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid Sources
1.4.2.2 Public Sources
Chapter 2 Executive Summary
2.1 Global nicotinamide adenine dinucleotide industry 3600 synopsis, 2022 - 2030
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Grade trends
2.1.4 Application trends
Chapter 3 Nicotinamide Adenine Dinucleotide Industry Insights
3.1 Industry segmentation
3.2 Industry ecosystem analysis
3.2.1 Raw material suppliers
3.2.2 Manufacturers
3.2.3 End-use
3.2.4 Distribution channel analysis
3.2.5 Profit margin trends
3.2.6 Vendor matrix
3.2.7 Impact of COVID-19 on industry value chain
3.3 Raw material analysis
3.4 Technology landscape
3.4.1 Enzymatic process
3.4.2 Chemical process
3.5 Regulatory landscape
3.5.1 U.S
3.5.2 Europe
3.5.3 China
3.6 Pricing trends, by region (2017 to 2030)
3.6.1 Regional Pricing
3.6.1.1 North America
3.6.1.2 Europe
3.6.1.3 Asia Pacific
3.6.1.4 LATAM
3.6.1.5 MEA
3.6.2 COVID-19 impact on pricing trends
3.6.3 Cost structure analysis, 2021
3.7 Industry impact forces
3.7.1 Growth drivers
3.7.1.1 Growing utilization and demand from pharmaceutical industry
3.7.1.2 The growing consumer demand for anti-aging products
3.7.2 Industry pitfalls & challenges
3.7.2.1 Stringent norms on the dosage use to prevent adverse health effects
3.8 Innovation & sustainability
3.9 Growth potential analysis, 2021
3.10 Porter's analysis
3.11 PESTEL analysis
3.12 Impact of COVID-19 on nicotinamide adenine dinucleotide market, by application
3.12.1 Dietary Supplements
3.12.2 Pharmaceuticals
3.12.3 Anti-aging Products
3.12.4 Others
3.13 Global anti-aging ingredients market outlook and the Role of NAD+ in anti-aging therapies
3.14 Impact of covid-19 on world economy
3.15 Impact of Russia-Ukraine war impact on nicotinamide adenine dinucleotide market
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company market share, 2021
4.3 Competitive analysis of major market players
4.4 Vendor adoption matrix
4.5 Strategic outlook matrix
Chapter 5 Nicotinamide Adenine Dinucleotide Market, By Grade
5.1 Key grade trends
5.2 Food Grade
5.2.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
5.2.2 Market estimates and forecast, by region, 2017 – 2030, (Tons) (USD Million)
5.3 Pharmaceutical Grade
5.3.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
5.3.2 Market estimates and forecast, by region, 2017 – 2030, (Tons) (USD Million)
5.4 Others
5.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
5.4.2 Market estimates and forecast, by region, 2017 – 2030, (Tons) (USD Million)
Chapter 6 Nicotinamide Adenine Dinucleotide Market, By Application
6.1 Key application trends
6.2 Dietary Supplements
6.2.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
6.2.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
6.3 Pharmaceuticals
6.3.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
6.3.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
6.4 Anti-aging Products
6.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
6.4.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
6.5 Others
6.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
6.5.2 Market estimates and forecast, by region, 2017 - 2030, (Tons) (USD Million)
Chapter 7 Nicotinamide Adenine Dinucleotide Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.2.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.2.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.2.4 U.S.
7.2.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.2.4.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.2.4.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.2.5 Canada
7.2.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.2.5.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.2.5.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.3 Europe
7.3.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.3.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.3.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.3.4 Germany
7.3.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.3.4.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.3.4.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.3.5 UK
7.3.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.3.5.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.3.5.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.3.6 France
7.3.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.3.6.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.3.6.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.3.7 Italy
7.3.7.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.3.7.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.3.7.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.3.8 Russia
7.3.8.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.3.8.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.3.8.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.3.9 Spain
7.3.9.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.3.9.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.3.9.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.4 Asia Pacific
7.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.4.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.4.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.4.4 China
7.4.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.4.4.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.4.4.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.4.5 India
7.4.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.4.5.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.4.5.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.4.6 Japan
7.4.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.4.6.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.4.6.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.4.7 South Korea
7.4.7.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.4.7.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.4.7.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.4.8 Australia
7.4.8.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.4.8.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.4.8.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.5 Latin America (LATAM)
7.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.5.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.5.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.5.4 Brazil
7.5.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.5.4.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.5.4.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.5.5 Argentina
7.5.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.5.5.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.5.5.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.5.6 Mexico
7.5.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.5.6.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.5.6.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.6.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.6.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.6.4 Saudi Arabia
7.6.4.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.6.4.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.6.4.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.6.5 UAE
7.6.5.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.6.5.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.6.5.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
7.6.6 South Africa
7.6.6.1 Market estimates and forecast, 2017 - 2030, (Tons) (USD Million)
7.6.6.2 Market estimates and forecast, by grade, 2017 –2030, (Tons) (USD Million)
7.6.6.3 Market estimates and forecast, by application, 2017 –2030, (Tons) (USD Million)
Chapter 8 Company Profiles
8.1 Bontac Bioengineering
8.1.1 Business Overview
8.1.2 Financial Data
8.1.3 Product Landscape
8.1.4 Strategic Outlook
8.1.5 SWOT Analysis
8.2 Hefei Home Sunshine Pharmaceutical Technology Co., Ltd.
8.2.1 Business Overview
8.2.2 Financial Data
8.2.3 Product Landscape
8.2.4 SWOT Analysis
8.2.5 Strategic Outlook
8.3 F. Hoffmann-La Roche Ltd
8.3.1 Business Overview
8.3.2 Financial Data
8.3.3 Product Landscape
8.3.4 Strategic Outlook
8.3.5 SWOT Analysis
8.4 HiMedia Laboratories
8.4.1 Business Overview
8.4.2 Financial Data
8.4.3 Product Landscape
8.4.4 Strategic Outlook
8.4.5 SWOT Analysis
8.5 NutriScience Innovations, LLC
8.5.1 Business Overview
8.5.2 Financial Data
8.5.3 Product Landscape
8.5.4 Strategic Outlook
8.5.5 SWOT Analysis
8.6 Nutrifoods
8.6.1 Business Overview
8.6.2 Financial Data
8.6.3 Product Landscape
8.6.4 Strategic Outlook
8.6.5 SWOT Analysis
8.7 Bontac Bio-engineering(shenzhen)Co.,Ltd
8.7.1 Business Overview
8.7.2 Financial Data
8.7.3 Product Landscape
8.7.4 Strategic Outlook
8.7.5 SWOT Analysis
8.8 Krackeler Scientific
8.8.1 Business Overview
8.8.2 Financial Data
8.8.3 Product Landscape
8.8.4 Strategic Outlook
8.8.5 SWOT Analysis
8.9 Shandong Lankang Bio-Technology Co., Ltd.
8.9.1 Business Overview
8.9.2 Financial Data
8.9.3 Product Landscape
8.9.4 Strategic Outlook
8.9.5 SWOT Analysis
8.10 OYC Americas, Inc.
8.10.1 Business Overview
8.10.2 Financial Data
8.10.3 Product Landscape
8.10.4 Strategic Outlook
8.10.5 SWOT Analysis
8.11 Xi'an Yinherb Bio-Tech Co., Ltd
8.11.1 Business Overview
8.11.2 Financial Data
8.11.3 Product Landscape
8.11.4 Strategic Outlook
8.11.5 SWOT Analysis
8.12 Shenzhen Hygieia Biotechnology Co., Ltd
8.12.1 Business Overview
8.12.2 Financial Data
8.12.3 Product Landscape
8.12.4 Strategic Outlook
8.12.5 SWOT Analysis
8.13 Zhejiang Dazhan Biotechnology Co., Ltd.
8.13.1 Business Overview
8.13.2 Financial Data
8.13.3 Product Landscape
8.13.4 Strategic Outlook
8.13.5 SWOT Analysis
8.14 Otto Chemie Pvt. Ltd.
8.14.1 Business Overview
8.14.2 Financial Data
8.14.3 Product Landscape
8.14.4 Strategic Outlook
8.14.5 SWOT Analysis
8.15 Uthever
8.15.1 Business Overview
8.15.2 Financial Data
8.15.3 Product Landscape
8.15.4 Strategic Outlook
8.15.5 SWOT Analysis
